Lymphomatoid granulomatosis risk factors: Difference between revisions
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Lymphomatoid granulomatosis}} | {{Lymphomatoid granulomatosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{kakbar}} | ||
==Overview== | ==Overview== | ||
The risk factor this disease is commonly [[Epstein Barr virus|EBV]] infection . One my also develop it in a [[Immunodeficiency|immunodeficient]] state, organ transplantation , and [[Human Immunodeficiency Virus (HIV)|HIV]] infection. | The risk factor this disease is commonly [[Epstein Barr virus|EBV]] infection . One my also develop it in a [[Immunodeficiency|immunodeficient]] state, organ transplantation , and [[Human Immunodeficiency Virus (HIV)|HIV]] infection. | ||
Revision as of 20:51, 18 December 2018
|
Lymphomatoid granulomatosis Microchapters |
|
Differentiating Lymphomatoid granulomatosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphomatoid granulomatosis risk factors On the Web |
|
American Roentgen Ray Society Images of Lymphomatoid granulomatosis risk factors |
|
Directions to Hospitals Treating Lymphomatoid granulomatosis |
|
Risk calculators and risk factors for Lymphomatoid granulomatosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kamal Akbar, M.D.[2]
Overview
The risk factor this disease is commonly EBV infection . One my also develop it in a immunodeficient state, organ transplantation , and HIV infection.
Risk Factors
The most potent risk factor in the development of Lymphomatoid granulomatosis is EBV infection. Other risk factors include Drug induced immunodeficiency, Immunodeficient diseases, and HIV infection, and organ transplantation.[1][2]
Common Risk Factors
- Common risk factors in the development of Lymphamatoid granulomatosis include:
References
- ↑ Neparidze N, Lacy J (2014). "Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments". Clin Adv Hematol Oncol. 12 (6): 358–71. PMID 25003566.
- ↑ Dojcinov SD, Fend F, Quintanilla-Martinez L (2018). "EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts". Pathogens. 7 (1). doi:10.3390/pathogens7010028. PMC 5874754. PMID 29518976.
- ↑ Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L, Davies-Hill T, Raffeld M, Wilson WH, Jaffe ES (February 2015). "Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations". Am. J. Surg. Pathol. 39 (2): 141–56. doi:10.1097/PAS.0000000000000328. PMC 4293220. PMID 25321327.
- ↑ Costiniuk, Cecilia T.; Karamchandani, Jason; Bessissow, Ali; Routy, Jean-Pierre; Szabo, Jason; Frenette, Charles (2018). "Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report". BMC Infectious Diseases. 18 (1). doi:10.1186/s12879-018-3128-3. ISSN 1471-2334.
- ↑ Barakat, Athar; Grover, Karan; Peshin, Rohit (2014). "Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis". SpringerPlus. 3 (1): 751. doi:10.1186/2193-1801-3-751. ISSN 2193-1801.
- ↑ Shah, Sujal; Smith, Megan; Butler, Randall (2018). "A Case of Hodgkin Lymphoma Mimicking Lymphomatoid Granulomatosis Diagnosed at Autopsy". Laboratory Medicine. 49 (1): 80–86. doi:10.1093/labmed/lmx065. ISSN 0007-5027.